AstraZeneca appoints Citibank, N.A. as depositary bank for its U.S. American Depositary Receipt (ADR) Programme
6 February 2015Download further information (PDF 27kb)
Fourth quarter and full year results 2014
5 February 2015
AstraZeneca announced fourth quarter and full year results for 2014 on Thursday 5th February 2015. Presentations were made by Pascal Soriot, Chief Executive Officer; Marc Dunoyer, Chief Financial Officer; Briggs Morrison, EVP Global Medicines Development and Luke Miels EVP GPPS.